United States Biotechnology & Medical Research

Personalis, Inc. (PSNL)

Track

Track

Personalis Inc. executives have engaged in significant selling activity over the past ninety days, totaling over ten million dollars. Despite a nearly thirty percent stock price increase, leadership including the CEO and CFO offloaded shares. These transactions follow a recent earnings report that missed expectations, occurring amidst elevated market valuation levels for the healthcare firm.
Ticker: PSNL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Personalis, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.6
Hall Christopher M Chief Executive Officer Executive Director
Transaction date
Sale
Price
233.55
Quantity 51,858 -2.3%
Value US$4,879,497
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
55.64
Quantity 530 -8.4%
Value US$2,062,160
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
489.16
Quantity 55,388 -3.1%
Value US$4,287,804
3.1
Chen Richard President and CMO Officer
Transaction date
Sale
Price
16.22
Quantity 1,000 -2.3%
Value US$100,000
3.1
Chen Richard President and CMO Officer
Transaction date
Planned sale
Price
15.15
Quantity 100,000 -36.5%
Value US$1,515,000
3.1
RICHARD CHEN Officer Officer
Transaction date
Proposed sale
Price
15.03
Quantity 100,000
Value US$1,503,000
2.6
Hall Christopher M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
15.08
Quantity 100,000 -29.8%
Value US$1,508,000
2.6
Chris Hall Director; Officer Executive Director
Transaction date
Proposed sale
Price
14.11
Quantity 100,000
Value US$1,411,000
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
14.00
Quantity 4,982 -2.4%
Value US$69,748
3.4
AARON TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
13.02
Quantity 4,982
Value US$64,866
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
13.18
Quantity 51,251 -20.5%
Value US$675,488
2.6
Hall Christopher M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
13.15
Quantity 100,000 -29.8%
Value US$1,315,000
3.4
AARON TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
12.59
Quantity 51,251
Value US$645,250
2.6
Chris Hall Director; Officer Executive Director
Transaction date
Proposed sale
Price
12.59
Quantity 100,000
Value US$1,259,000
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
12.01
Quantity 40,000 -16.7%
Value US$480,400
3.4
AARON TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
10.78
Quantity 40,000
Value US$431,200
2.6
Hall Christopher M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
11.02
Quantity 80,091 -25.3%
Value US$882,603
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
11.58
Quantity 38,799 -16.3%
Value US$449,292
3.4
AARON TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
10.98
Quantity 38,799
Value US$426,013
2.6
Hall Christopher M Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
11.02
Quantity 19,909 -7.8%
Value US$219,397
2.6
CHRISTOPHER HALL Director; Officer Executive Director
Transaction date
Proposed sale
Price
9.49
Quantity 100,000
Value US$949,000
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
11.50
Quantity 1,201 -0.7%
Value US$13,812
3.4
AARON L TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
9.65
Quantity 40,000
Value US$386,000
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
8.93
Quantity 28,000 +0.2%
Value US$250,040
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
8.39
Quantity 29,641 +0.2%
Value US$248,688
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
7.91
Quantity 31,430 +0.2%
Value US$248,611
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
7.86
Quantity 31,650 +0.2%
Value US$248,769
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
11.00
Quantity 13,888 +0.1%
Value US$152,768
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
10.08
Quantity 9,712 +0.1%
Value US$97,897
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Planned sale
Price
10.78
Quantity 103,668 -38.7%
Value US$1,117,541
3.4
AARON L TACHIBANA Officer Officer
Transaction date
Proposed sale
Price
9.99
Quantity 103,668
Value US$1,035,643
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
9.87
Quantity 25,225 +0.2%
Value US$248,971
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
9.74
Quantity 16,599 +0.1%
Value US$161,674
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
8.84
Quantity 9,900 +0.1%
Value US$87,516
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
8.63
Quantity 28,827 +0.2%
Value US$248,777
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
8.12
Quantity 30,645 +0.2%
Value US$248,837
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
7.67
Quantity 64,750 +0.5%
Value US$496,632
2.6
Hall Christopher M PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
8.99
Quantity 29,612 -16.6%
Value US$266,212
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
6.57
Quantity 641 -0.4%
Value US$4,211
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
6.57
Quantity 452 -0.4%
Value US$2,970
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Planned sale
Price
4.95
Quantity 910 -0.7%
Value US$4,504
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
4.95
Quantity 1,291 -0.8%
Value US$6,390
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
4.95
Quantity 1,675 -2.5%
Value US$8,291
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
5.79
Quantity 708 -0.4%
Value US$4,099
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
5.79
Quantity 519 -0.4%
Value US$3,005
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
3.82
Quantity 4,834 -3.8%
Value US$18,466
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
3.82
Quantity 1,513 -2.2%
Value US$5,780
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
3.82
Quantity 6,865 -3.9%
Value US$26,224
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
3.79
Quantity 1,693 -2.5%
Value US$6,416
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Planned sale
Price
3.79
Quantity 921 -0.7%
Value US$3,491
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
3.79
Quantity 1,307 -0.7%
Value US$4,954
2.6
Hall Christopher M PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
5.38
Quantity 26,443 -12.9%
Value US$142,263
2.2
Tempus AI, Inc. Large shareholder
Transaction date
Purchase
Price
5.07
Quantity 3,500,000 +38.0%
Value US$17,745,000
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
2.97
Quantity 524 -0.4%
Value US$1,556
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
2.97
Quantity 742 -0.4%
Value US$2,204
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
1.29
Quantity 1,585 -2.2%
Value US$2,045
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
1.29
Quantity 5,055 -3.8%
Value US$6,521
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
1.29
Quantity 7,176 -3.9%
Value US$9,257
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
1.38
Quantity 1,333 -0.7%
Value US$1,840
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Planned sale
Price
1.38
Quantity 940 -0.7%
Value US$1,297
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
1.38
Quantity 1,731 -2.4%
Value US$2,389
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
1.38
Quantity 1,731 -2.4%
Value US$2,389
3.0
Moore Stephen Michael SVP and Chief Legal Officer Officer
Transaction date
Sale
Price
1.37
Quantity 4,523 -5.9%
Value US$6,197
0.6
MYERS WOODROW A JR Non-Executive Director
Transaction date
Purchase
Price
1.67
Quantity 10,000 +62.1%
Value US$16,700
3.1
Chen Richard CHIEF MEDICAL OFFICER AND EVP Officer
Transaction date
Sale
Price
1.37
Quantity 526 -0.4%
Value US$721
3.4
Tachibana Aaron CFO AND COO Officer
Transaction date
Sale
Price
1.37
Quantity 716 -0.4%
Value US$981
3.1
Chen Richard Chief Medical Officer and EVP Officer
Transaction date
Planned sale
Price
1.47
Quantity 4,708 -3.5%
Value US$6,921
3.4
Tachibana Aaron CFO and COO Officer
Transaction date
Sale
Price
1.47
Quantity 6,747 -3.5%
Value US$9,918
3.0
Moore Stephen Michael General Counsel Officer
Transaction date
Sale
Price
1.47
Quantity 1,476 -1.9%
Value US$2,170
3.4
Tachibana Aaron CFO and COO Officer
Transaction date
Sale
Price
1.04
Quantity 1,344 -0.7%
Value US$1,398
3.1
Chen Richard Chief Medical Officer and EVP Officer
Transaction date
Sale
Price
1.04
Quantity 940 -0.8%
Value US$978
3.0
Moore Stephen Michael General Counsel Officer
Transaction date
Sale
Price
1.04
Quantity 1,722 -2.1%
Value US$1,791
2.6
Hall Christopher M President and CEO Executive Director
Transaction date
Sale
Price
0.93
Quantity 20,459 -9.1%
Value US$19,027
3.1
Chen Richard Chief Medical Officer and EVP Officer
Transaction date
Sale
Price
2.26
Quantity 485 -0.4%
Value US$1,096
3.4
Tachibana Aaron CFO and COO Officer
Transaction date
Sale
Price
2.26
Quantity 662 -0.3%
Value US$1,496
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-22 2026-09-18 S Sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
51,858 -2.3%
233.55
US$4,879,497 		51,858 -2.3% 233.55 US$4,879,497
2026-09-22 2026-09-18 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
530 -8.4%
55.64
US$2,062,160 		530 -8.4% 55.64 US$2,062,160
2026-09-22 2026-09-18 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
55,388 -3.1%
489.16
US$4,287,804 		55,388 -3.1% 489.16 US$4,287,804
2026-09-22 2026-09-18 S Sale
3.1
Chen Richard

President and CMO

Officer
1,000 -2.3%
16.22
US$100,000 		1,000 -2.3% 16.22 US$100,000
2026-07-15 2026-07-15 PlS Planned sale
3.1
Chen Richard

President and CMO

Officer
100,000 -36.5%
15.15
US$1,515,000 		100,000 -36.5% 15.15 US$1,515,000
2026-07-15 2026-07-15 PrS Proposed sale
3.1
RICHARD CHEN

Officer

Officer
100,000
15.03
US$1,503,000 		100,000 15.03 US$1,503,000
2026-07-09 2026-07-09 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
100,000 -29.8%
15.08
US$1,508,000 		100,000 -29.8% 15.08 US$1,508,000
2026-07-09 2026-07-09 PrS Proposed sale
2.6
Chris Hall

Director; Officer

Executive Director
100,000
14.11
US$1,411,000 		100,000 14.11 US$1,411,000
2026-06-29 2026-06-29 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
4,982 -2.4%
14.00
US$69,748 		4,982 -2.4% 14.00 US$69,748
2026-06-29 2026-06-29 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
4,982
13.02
US$64,866 		4,982 13.02 US$64,866
2026-06-26 2026-06-26 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
51,251 -20.5%
13.18
US$675,488 		51,251 -20.5% 13.18 US$675,488
2026-06-26 2026-06-26 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
100,000 -29.8%
13.15
US$1,315,000 		100,000 -29.8% 13.15 US$1,315,000
2026-06-26 2026-06-26 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
51,251
12.59
US$645,250 		51,251 12.59 US$645,250
2026-06-26 2026-06-26 PrS Proposed sale
2.6
Chris Hall

Director; Officer

Executive Director
100,000
12.59
US$1,259,000 		100,000 12.59 US$1,259,000
2026-06-05 2026-06-04 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
40,000 -16.7%
12.01
US$480,400 		40,000 -16.7% 12.01 US$480,400
2026-06-04 2026-06-04 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
40,000
10.78
US$431,200 		40,000 10.78 US$431,200
2026-05-29 2026-05-29 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
80,091 -25.3%
11.02
US$882,603 		80,091 -25.3% 11.02 US$882,603
2026-05-29 2026-05-29 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
38,799 -16.3%
11.58
US$449,292 		38,799 -16.3% 11.58 US$449,292
2026-05-29 2026-05-29 PrS Proposed sale
3.4
AARON TACHIBANA

Officer

Officer
38,799
10.98
US$426,013 		38,799 10.98 US$426,013
2026-05-29 2026-05-28 PlS Planned sale
2.6
Hall Christopher M

Chief Executive Officer

Executive Director
19,909 -7.8%
11.02
US$219,397 		19,909 -7.8% 11.02 US$219,397
2026-05-28 2026-05-28 PrS Proposed sale
2.6
CHRISTOPHER HALL

Director; Officer

Executive Director
100,000
9.49
US$949,000 		100,000 9.49 US$949,000
2026-01-23 2026-01-22 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,201 -0.7%
11.50
US$13,812 		1,201 -0.7% 11.50 US$13,812
2026-01-22 2026-01-22 PrS Proposed sale
3.4
AARON L TACHIBANA

Officer

Officer
40,000
9.65
US$386,000 		40,000 9.65 US$386,000
2026-02-13 2025-12-22 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
28,000 +0.2%
8.93
US$250,040 		28,000 +0.2% 8.93 US$250,040
2026-02-13 2025-12-19 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
29,641 +0.2%
8.39
US$248,688 		29,641 +0.2% 8.39 US$248,688
2026-02-13 2025-12-18 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
31,430 +0.2%
7.91
US$248,611 		31,430 +0.2% 7.91 US$248,611
2026-02-13 2025-12-17 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
31,650 +0.2%
7.86
US$248,769 		31,650 +0.2% 7.86 US$248,769
2026-02-13 2025-11-25 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
13,888 +0.1%
11.00
US$152,768 		13,888 +0.1% 11.00 US$152,768
2026-02-13 2025-11-25 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
9,712 +0.1%
10.08
US$97,897 		9,712 +0.1% 10.08 US$97,897
2025-11-28 2025-11-25 PlS Planned sale
3.4
Tachibana Aaron

CFO AND COO

Officer
103,668 -38.7%
10.78
US$1,117,541 		103,668 -38.7% 10.78 US$1,117,541
2025-11-25 2025-11-25 PrS Proposed sale
3.4
AARON L TACHIBANA

Officer

Officer
103,668
9.99
US$1,035,643 		103,668 9.99 US$1,035,643
2026-02-13 2025-11-24 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
25,225 +0.2%
9.87
US$248,971 		25,225 +0.2% 9.87 US$248,971
2026-02-13 2025-11-21 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
16,599 +0.1%
9.74
US$161,674 		16,599 +0.1% 9.74 US$161,674
2026-02-13 2025-11-21 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
9,900 +0.1%
8.84
US$87,516 		9,900 +0.1% 8.84 US$87,516
2026-02-13 2025-11-20 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
28,827 +0.2%
8.63
US$248,777 		28,827 +0.2% 8.63 US$248,777
2026-02-13 2025-11-19 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
30,645 +0.2%
8.12
US$248,837 		30,645 +0.2% 8.12 US$248,837
2026-02-13 2025-11-18 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
64,750 +0.5%
7.67
US$496,632 		64,750 +0.5% 7.67 US$496,632
2025-11-05 2025-11-03 S Sale
2.6
Hall Christopher M

PRESIDENT AND CEO

Executive Director
29,612 -16.6%
8.99
US$266,212 		29,612 -16.6% 8.99 US$266,212
2025-07-30 2025-07-28 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
641 -0.4%
6.57
US$4,211 		641 -0.4% 6.57 US$4,211
2025-07-30 2025-07-28 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
452 -0.4%
6.57
US$2,970 		452 -0.4% 6.57 US$2,970
2025-05-20 2025-05-16 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
910 -0.7%
4.95
US$4,504 		910 -0.7% 4.95 US$4,504
2025-05-20 2025-05-16 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,291 -0.8%
4.95
US$6,390 		1,291 -0.8% 4.95 US$6,390
2025-05-20 2025-05-16 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,675 -2.5%
4.95
US$8,291 		1,675 -2.5% 4.95 US$8,291
2025-01-30 2025-01-28 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
708 -0.4%
5.79
US$4,099 		708 -0.4% 5.79 US$4,099
2025-01-30 2025-01-28 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
519 -0.4%
5.79
US$3,005 		519 -0.4% 5.79 US$3,005
2024-12-18 2024-12-16 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
4,834 -3.8%
3.82
US$18,466 		4,834 -3.8% 3.82 US$18,466
2024-12-18 2024-12-16 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,513 -2.2%
3.82
US$5,780 		1,513 -2.2% 3.82 US$5,780
2024-12-18 2024-12-16 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
6,865 -3.9%
3.82
US$26,224 		6,865 -3.9% 3.82 US$26,224
2024-11-20 2024-11-18 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,693 -2.5%
3.79
US$6,416 		1,693 -2.5% 3.79 US$6,416
2024-11-20 2024-11-18 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
921 -0.7%
3.79
US$3,491 		921 -0.7% 3.79 US$3,491
2024-11-20 2024-11-18 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,307 -0.7%
3.79
US$4,954 		1,307 -0.7% 3.79 US$4,954
2024-11-05 2024-11-01 S Sale
2.6
Hall Christopher M

PRESIDENT AND CEO

Executive Director
26,443 -12.9%
5.38
US$142,263 		26,443 -12.9% 5.38 US$142,263
2024-08-20 2024-08-16 B Purchase
2.2
Tempus AI, Inc.
Large shareholder
3,500,000 +38.0%
5.07
US$17,745,000 		3,500,000 +38.0% 5.07 US$17,745,000
2024-08-01 2024-07-30 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
524 -0.4%
2.97
US$1,556 		524 -0.4% 2.97 US$1,556
2024-08-01 2024-07-30 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
742 -0.4%
2.97
US$2,204 		742 -0.4% 2.97 US$2,204
2024-06-20 2024-06-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,585 -2.2%
1.29
US$2,045 		1,585 -2.2% 1.29 US$2,045
2024-06-20 2024-06-17 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
5,055 -3.8%
1.29
US$6,521 		5,055 -3.8% 1.29 US$6,521
2024-06-20 2024-06-17 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
7,176 -3.9%
1.29
US$9,257 		7,176 -3.9% 1.29 US$9,257
2024-05-21 2024-05-17 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
1,333 -0.7%
1.38
US$1,840 		1,333 -0.7% 1.38 US$1,840
2024-05-21 2024-05-17 PlS Planned sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
940 -0.7%
1.38
US$1,297 		940 -0.7% 1.38 US$1,297
2024-05-21 2024-05-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,731 -2.4%
1.38
US$2,389 		1,731 -2.4% 1.38 US$2,389
2024-05-21 2024-05-17 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
1,731 -2.4%
1.38
US$2,389 		1,731 -2.4% 1.38 US$2,389
2024-05-02 2024-04-30 S Sale
3.0
Moore Stephen Michael

SVP and Chief Legal Officer

Officer
4,523 -5.9%
1.37
US$6,197 		4,523 -5.9% 1.37 US$6,197
2024-03-05 2024-03-01 B Purchase
0.6
MYERS WOODROW A JR
Non-Executive Director
10,000 +62.1%
1.67
US$16,700 		10,000 +62.1% 1.67 US$16,700
2024-01-31 2024-01-29 S Sale
3.1
Chen Richard

CHIEF MEDICAL OFFICER AND EVP

Officer
526 -0.4%
1.37
US$721 		526 -0.4% 1.37 US$721
2024-01-31 2024-01-29 S Sale
3.4
Tachibana Aaron

CFO AND COO

Officer
716 -0.4%
1.37
US$981 		716 -0.4% 1.37 US$981
2023-12-19 2023-12-15 PlS Planned sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
4,708 -3.5%
1.47
US$6,921 		4,708 -3.5% 1.47 US$6,921
2023-12-19 2023-12-15 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
6,747 -3.5%
1.47
US$9,918 		6,747 -3.5% 1.47 US$9,918
2023-12-19 2023-12-15 S Sale
3.0
Moore Stephen Michael

General Counsel

Officer
1,476 -1.9%
1.47
US$2,170 		1,476 -1.9% 1.47 US$2,170
2023-11-20 2023-11-16 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
1,344 -0.7%
1.04
US$1,398 		1,344 -0.7% 1.04 US$1,398
2023-11-20 2023-11-16 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
940 -0.8%
1.04
US$978 		940 -0.8% 1.04 US$978
2023-11-20 2023-11-16 S Sale
3.0
Moore Stephen Michael

General Counsel

Officer
1,722 -2.1%
1.04
US$1,791 		1,722 -2.1% 1.04 US$1,791
2023-11-03 2023-11-01 S Sale
2.6
Hall Christopher M

President and CEO

Executive Director
20,459 -9.1%
0.93
US$19,027 		20,459 -9.1% 0.93 US$19,027
2023-08-02 2023-07-31 S Sale
3.1
Chen Richard

Chief Medical Officer and EVP

Officer
485 -0.4%
2.26
US$1,096 		485 -0.4% 2.26 US$1,096
2023-08-02 2023-07-31 S Sale
3.4
Tachibana Aaron

CFO and COO

Officer
662 -0.3%
2.26
US$1,496 		662 -0.3% 2.26 US$1,496
Explore more

More insider trading research around Personalis, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America